Quarterly report · Q2
9341.TEDINET S100S8BS
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥6.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥970m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥696m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥971m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥700m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥971m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥702m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥626m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥438m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥629m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥439m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥6.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥5.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.8bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥577m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥434m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥126m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥113m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥71m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥107m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥109m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.37 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.01 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.61 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.08 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.07 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 74.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥274m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥274m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥73m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥727m |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥983m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥983m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥153m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥267m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥267m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥83m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥557m |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E38215-000Medical Platform Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥985m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥841m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥841m |
| jpcrp040300-q2r_E38215-000Smart Clinic Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥184m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 464
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)柳 承煥 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山内 紀彰 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 2916323000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 3980686000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 6513466000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 699518000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 971028000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1714898000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 438222000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 626011000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1260112000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 439225000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 629370000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1262552000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 1931564000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 4814982000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 4046873000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 3060037000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 6279885000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 5414923000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 27.08 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 35.37 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 76.61 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 35.08 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 73.07 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.629 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.746 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.746 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 433576000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 577057000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1203079000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -71467000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -125845000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -113450000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -109015000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 106671000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 1131226000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 1893269000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 4418953000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3860506000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 14.30 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 19.01 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17760100 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17760100 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17760100 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17760100 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |